Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00471068 |
To compare the efficacy and safety in patients treated with travoprost versus dorzolamide/timolol maleate combination in patients with open-angle glaucoma or ocular hypertension
Condition | Intervention | Phase |
---|---|---|
Open-Angle Glaucoma Ocular Hypertension |
Drug: Travatan |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Alcon ( Anna Grau ) |
Study ID Numbers: | EMD-05-03 |
Study First Received: | May 8, 2007 |
Last Updated: | October 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00471068 History of Changes |
Health Authority: | Infarmed:Portugal |
Glaucoma Eye Diseases Glaucoma, Open-Angle Vascular Diseases Cardiovascular Agents |
Antihypertensive Agents Travoprost Hypertension Ocular Hypertension |
Glaucoma Therapeutic Uses Eye Diseases Glaucoma, Open-Angle Vascular Diseases Cardiovascular Diseases |
Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions Travoprost Ocular Hypertension Hypertension |